WHITE PLAINS, N.Y., Oct. 3 /PRNewswire/ -- The National Institutes of Health (NIH) has awarded a major monetary two phase grant through its SBIR (Small Business Innovation Research) Program to CAD Sciences to develop, in collaboration with clinical investigators, a specific application of the Company's proprietary pharmacokinetic analysis technology for the characterization of cancerous lung nodules using contrast-enhanced MRI.
According to Andreas Muehler, M.D., President of CAD Sciences, "The award of an SBIR grant to CAD Sciences validates the approach that our team has taken over the last several years to focus on scientific development of our core technologies in order to maintain a strong leadership position in CAD for contrast-enhanced MRI and CT. We continually strive to develop products that are based on a solid scientific foundation and validation by clinical collaborators. I personally believe that commercial success follows good science and good medicine."
The SBIR Program is a highly competitive award system that provides qualified small business concerns with opportunities to propose innovative ideas that meet the specific research and development needs of the Federal Government. The first phase of the grant will fund the Company's research through August 31, 2007 to show feasibility for a novel, minimally-invasive method to characterize lung malignancies using magnetic resonance imaging. All intellectual rights to inventions created will be the property of CAD Sciences provided it adheres to certain federally mandated restrictions that are customary for NIH grants.
About CAD Sciences:
Founded in March 2002, CAD Sciences is the technology leader in the advancement of computer-assisted modeling of contrast enhancement in MR imaging of cancer. From its base in White Plains, NY, the Company designs and internationally distributes certain intellectual property in CAD (Computer Assisted Diagnosis) and MRA (Magnetic Resonance Angiography) software for medical imaging. The Company's Server2(TM) and WorkSpace software platforms are currently used by radiologist customers to facilitate the analysis, interventional planning and reporting of breast and prostate MRI. Together these products automate MRI image processing and provide higher quality imaging studies, lower facility costs, increased revenue streams for radiology practices as well as improved analysis and reporting tools for physicians.
More information about the Company or its technology can be obtained by visiting www.cadsciences.com or by calling our office at (877) 387-4387.
Media Contacts:
Raymond E. Joslin, (914) 313-0330, raymond.joslin@cadsciences.com
Nancy Isenberger, (914) 313-0409, nancy.isenberger@cadsciences.com
CAD SciencesCONTACT: Raymond E. Joslin, +1-914-313-0330,raymond.joslin@cadsciences.com, or Nancy Isenberger, +1-914-313-0409,nancy.isenberger@cadsciences.com, both of CAD Sciences
Web site: http://www.cadsciences.com/
